Insmed Incorporated
INSM
$68.12
$0.901.34%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -256.58M | -235.55M | -220.52M | -300.61M | -157.09M |
Total Depreciation and Amortization | 2.61M | 2.21M | 2.19M | 2.16M | 2.32M |
Total Amortization of Deferred Charges | 3.03M | 2.96M | 2.70M | 3.01M | 3.06M |
Total Other Non-Cash Items | 54.94M | 6.28M | 50.45M | 132.92M | 22.81M |
Change in Net Operating Assets | -66.09M | 28.12M | -15.73M | 39.56M | -55.13M |
Cash from Operations | -262.09M | -195.98M | -180.92M | -122.95M | -184.04M |
Capital Expenditure | -10.07M | -6.77M | -3.69M | -6.78M | -4.68M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 90.48M | 138.53M | -999.78M | 0.00 | 300.00M |
Cash from Investing | 80.41M | 131.76M | -1.00B | -6.78M | 295.32M |
Total Debt Issued | -- | 150.00M | -- | -- | -- |
Total Debt Repaid | -706.00K | -686.00K | -658.00K | -645.00K | -621.00K |
Issuance of Common Stock | 29.70M | 13.73M | 397.86M | 781.73M | 4.05M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -3.74M | -- | 409.00K | -409.00K |
Cash from Financing | 29.00M | 159.31M | 397.20M | 781.49M | 3.02M |
Foreign Exchange rate Adjustments | 895.00K | -1.51M | 1.84M | -688.00K | -953.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -151.78M | 93.58M | -785.35M | 651.07M | 113.36M |